When is a clot not from a hypercoagulable state?

A well-known complication of atrial fibrillation for patients to form clots.

EDITOR’S NOTE: Dr. Remer reported this story during a recent edition of Talk Ten Tuesdays.

A while ago, Allen Frady and Dr. Ronald Hirsch were having a lively discussion on LinkedIn regarding atrial fibrillation and the diagnosis of D68.69, Other thrombophilia which is the code used for “secondary hypercoagulable state.” I thought I was going to be able to weigh in quickly and decisively, but I exceeded my character limit, so I am bringing the discussion here.

Primary hypercoagulable states are easier to identify. They are hereditary abnormalities of coagulation where a physiologic anticoagulant pathway is not properly functional. Examples are antithrombin III deficiency, protein C and S deficiencies, and dysfibrinogenemias. The checks and balances of clotting don’t work, so the patient clots excessively.

There are conditions of acquired hypercoagulability which are referred to as secondary hypercoagulable states. Examples of this are pregnancy, hormonal therapy such as birth control pills, malignancy, and hyperlipidemia.

Allen questioned whether we are missing the diagnosis of secondary hypercoagulable state. He referred to a presentation by Dr. Vladimir-Ducarmel Joseph who referenced Virchow’s triad and posed atrial fibrillation as being a hypercoagulable state. Since AF affects approximately 1 percent of the population, Allen wondered whether we are missing a prime opportunity to capture D68.69, a comorbid condition or complication (CC).

Virchow’s triad is a pathophysiological concept to explain an increased likelihood of developing thrombi. The three components of the triad are stasis or abnormal blood flow, endothelial injury, and hypercoagulability caused by abnormal blood constituents. The more factors the patient has, the higher the risk of developing a clot.

The title of D68.69 is Other thrombophilia. Thrombophilia is defined in the Merriam-Webster medical dictionary as, “a hereditary or acquired disorder marked by an abnormal increase in the tendency of blood to clot and higher than normal risk of thrombosis.”

It is a well-known complication of atrial fibrillation for patients to form clots, usually in the atrial appendage, and for these clots to be propelled into the brain circulation causing stroke. The risk is about 5 percent, per year on average. The older the patient, the higher the risk. Patients are often placed on anticoagulation prophylactically. They have a higher than normal risk of thrombosis, but thrombi are not forming on the basis of an abnormal tendency for the blood to clot.

My opinion is just having a propensity for developing a clot, especially in a specific location, does not constitute a hypercoagulable state. Thrombogenic, yes, hypercoagulable, no. Having an injury or a previous DVT does predispose a patient to developing a clot. That is not a hypercoagulable state to me. I think the key question is, “Is the patient generally predisposed to a clot anywhere in their body because their coagulation system is not functioning properly?”

The higher than normal risk of thrombosis from other thrombophilia is due to an abnormal tendency of the blood to clot, not situational. Patients with atrial fibrillation don’t have blood with a higher tendency to clot; the provider does a risk-benefit analysis and renders their blood less likely to clot with extrinsic anticoagulation.

Should the provider be documenting all pregnant women, all patients on hormones, all patients with malignancies with D68.69? Not unless they are taking those secondary hypercoagulable states into account and assessing or treating it. The condition must meet the criteria of a secondary diagnosis.

As I think about everything nowadays, what about COVID-19? Experts are not sure of the mechanism, but the coronavirus does seem to make some patients hypercoagulable. They have a tendency to develop clots in various locations. This does legitimately meet secondary hypercoagulable status.

The key is how did the provider document it? Are they treating it with anticoagulation? I think this is query-worthy, because epidemiologically speaking, knowing the incidence of hypercoagulability in COVID-19 would be important.

My vote is atrial fibrillation is not a “secondary hypercoagulable state.” There is literature that refers to it this way but prepare yourself for a denial appeal unless there are extenuating circumstances.

Facebook
Twitter
LinkedIn

Erica Remer, MD, FACEP, CCDS, ACPA-C

Erica Remer, MD, FACEP, CCDS, ACPA-C has a unique perspective as a practicing emergency physician for 25 years, with extensive coding, CDI, and ICD-10 expertise. As physician advisor for University Hospitals Health System in Cleveland, Ohio for four years, she trained 2,700 providers in ICD-10, closed hundreds of queries, fought numerous DRG clinical determination and medical necessity denials, and educated CDI specialists and healthcare providers with engaging, case-based presentations. She transitioned to independent consulting in July 2016. Dr. Remer is a member of the ICD10monitor editorial board and is the co-host on the popular Talk Ten Tuesdays weekly, live Internet radio broadcasts.

Related Stories

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

2026 IPPS Masterclass 3: Master MS-DRG Shifts and NTAPs

2026 IPPS Masterclass Day 3: MS-DRG Shifts and NTAPs

This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 14, 2025
2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

This second session in our 2026 IPPS Masterclass will feature a review the FY26 changes to ICD-10-PCS codes. This information will be presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 13, 2025
2026 IPPS Masterclass 1: Master ICD-10-CM Changes

2026 IPPS Masterclass Day 1: Master ICD-10-CM Changes

This first session in our 2026 IPPS Masterclass will feature an in-depth explanation of FY26 changes to ICD-10-CM codes and guidelines, CCs/MCCs, and revisions to the MCE, presented by presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 12, 2025

Trending News

Featured Webcasts

The Two-Midnight Rule: New Challenges, Proven Strategies

The Two-Midnight Rule: New Challenges, Proven Strategies

RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.

June 19, 2025
Open Door Forum Webcast Series

Open Door Forum Webcast Series

Bring your questions and join the conversation during this open forum series, live every Wednesday at 10 a.m. EST from June 11–July 30. Hosted by Chuck Buck, these fast-paced 30-minute sessions connect you directly with top healthcare experts tackling today’s most urgent compliance and policy issues.

June 11, 2025
Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Substance abuse is everywhere. It’s a complicated diagnosis with wide-ranging implications well beyond acute care. The face of addiction continues to change so it’s important to remember not just the addict but the spectrum of extended victims and the other social determinants and legal ramifications. Join John K. Hall, MD, JD, MBA, FCLM, FRCPC, for a critical Q&A on navigating substance abuse in 2025.  Register today and be a part of the conversation!

July 16, 2025

Trending News

Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more

Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24